I may have to write more -- again, here over a decade later -- on these rather appalling so-called "accelerated" approvals at the Commission level -- ones that do not require any actual proof of clinical benefit, just post market studies (to gauge whether there is any).
That is precisely the story of Vytorin®, as well.
Onward -- be excellent to one another.
नमस्ते
No comments:
Post a Comment